Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7094614 | 0.69 | HSD17B10 (0.38) | KDM4ECYP1A2GLACYP2C9HPGD | |
| SCHEMBL29748869 | 0.69 | ALDH1A1 (0.38) | KDM4ECYP1A2GLACYP2C9HPGD | |
| SCHEMBL3056466 | 0.65 | ALDH1A1 (0.41) | KDM4ECYP1A2GLACYP2C9HPGD | |
| Lithium SCHEMBL29650601 | 0.64 | CYP2A6 (0.39) | KDM4ECYP1A2GLACYP2C9HPGD | |
| SCHEMBL5657362 | 0.64 | WDR5 (0.43) | KDM4ECA12CA9CYP1A2GLA | |
| SCHEMBL29749091 | 0.64 | ALDH1A1 (0.39) | KDM4ECYP1A2HPGDCYP2C19HSD17B10 | |
| SCHEMBL7094272 | 0.62 | ABCG2 (0.40) | KDM4ECYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL994781 | 0.61 | CES1 (0.47) | KDM4ECYP1A2GLACYP2C9HPGD | |
| Hydrochloric Acid SCHEMBL25188850 | 0.60 | CES1 (0.46) | KDM4ECYP1A2GLACYP2C9HPGD | |
| SCHEMBL8519871 | 0.59 | ALDH1A1 (0.33) | KDM4ECYP1A2GLACYP2C9HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4741170-B2 | — | — | 2011-08-03 | — | — | JP | claimed |
| US-20100304381-A1 | FLUORESCENT NUCLEOBASE CONJUGATES HAVING ANIONIC LINKERS | Life Technologies Corporation (US) | 2010-12-02 | — | — | US | claimed |
| EP-1317464-B1 | FLUORESCENT NUCLEOBASE CONJUGATES HAVING ANIONIC LINKERS | APPLERA CORP (US) | 2009-05-13 | — | — | EP | claimed |
| WO-2008039997-A2 | NUCLEOBASE CONJUGATES WITH CATIONIC BACKBONE LINKERS | APPLERA CORPORATION (US) | 2008-04-03 | — | — | WO | claimed |
| EP-1317464-A2 | FLUORESCENT NUCLEOBASE CONJUGATES HAVING ANIONIC LINKERS | Applera Corporation (US) | 2003-06-11 | — | — | EP | claimed |
| US-20020102590-A1 | Fluorescent nucleobase conjugates having anionic linkers | PE CORPORATION (NY) (US) | 2002-08-01 | — | — | US | claimed |
| EP-1208160-A1 | RED-EMITTING 8,9]BENZOPHENOXAZINE NUCLEIC ACID DYES AND METHODS FOR THEIR USE | Applera Corporation (US) | 2002-05-29 | — | — | EP | claimed |
| WO-2002030944-A2 | FLUORESCENT NUCLEOBASE CONJUGATES HAVING ANIONIC LINKERS | APPLERA CORPORATION (US) | 2002-04-18 | — | — | WO | claimed |
| WO-2001018124-A1 | RED-EMITTING [8,9]BENZOPHENOXAZINE NUCLEIC ACID DYES AND METHODS FOR THEIR USE | APPLERA CORPORATION (US) | 2001-03-15 | — | — | WO | claimed |
| US-20140179901-A1 | Peptide Conjugates and Fluorescence Detection Methods for Intracellular Caspase Assay | APPLIED BIOSYSTEMS, LLC (US) | 2014-06-26 | — | — | US | disclosed |
| US-8623995-B2 | Peptide conjugates and fluorescence detection methods for intracellular caspase assay | APPLIED BIOSYSTEMS, LLC (US) | 2014-01-07 | — | — | US | disclosed |
| US-8003767-B2 | Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates | APPLIED BIOSYSTEMS, LLC (US) | 2011-08-23 | — | — | US | disclosed |
| US-20110097758-A1 | Peptide Conjugates and Fluorescence Detection Methods for Intracellular Caspase Assay | Life Technologies Corporation (US) | 2011-04-28 | — | — | US | disclosed |
| US-20100304381-A1 | FLUORESCENT NUCLEOBASE CONJUGATES HAVING ANIONIC LINKERS | Life Technologies Corporation (US) | 2010-12-02 | — | — | US | disclosed |
| WO-2001083621-A2 | SULFONATED [8,9]BENZOPHENOXAZINE DYES AND THE USE OF THEIR LABELLED CONJUGATES | APPLERA CORPORATION (US) | 2001-11-08 | — | — | WO | disclosed |
| WO-2001018124-A1 | RED-EMITTING [8,9]BENZOPHENOXAZINE NUCLEIC ACID DYES AND METHODS FOR THEIR USE | APPLERA CORPORATION (US) | 2001-03-15 | — | — | WO | disclosed |
| WO-2001018124-A1 | RED-EMITTING [8,9]BENZOPHENOXAZINE NUCLEIC ACID DYES AND METHODS FOR THEIR USE | APPLERA CORPORATION (US) | 2001-03-15 | — | — | WO | disclosed |
| US-6140500-A | THE NEW DYES ARE BRIGHTER AND PERMEATE CELLS FASTER THAN CURRENTLY AVAILABLE RED-EMITTING LIVE-CELL NUCLEIC ACID STAINS. | PE CORPORATION (US) | 2000-10-31 | — | — | US | disclosed |
| US-6140500-A | THE NEW DYES ARE BRIGHTER AND PERMEATE CELLS FASTER THAN CURRENTLY AVAILABLE RED-EMITTING LIVE-CELL NUCLEIC ACID STAINS. | PE CORPORATION (US) | 2000-10-31 | — | — | US | disclosed |
| US-6140500-A | THE NEW DYES ARE BRIGHTER AND PERMEATE CELLS FASTER THAN CURRENTLY AVAILABLE RED-EMITTING LIVE-CELL NUCLEIC ACID STAINS. | PE CORPORATION (US) | 2000-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179901-A1 | Peptide Conjugates and Fluorescence Detection Methods for Intracellular Caspase Assay | CASP5, CASP7, CASP12 | KDM4E 4554/4885CA12 1913/4885CA9 3802/4885 |
| US-20110097758-A1 | Peptide Conjugates and Fluorescence Detection Methods for Intracellular Caspase Assay | CASP5, CASP7, CASP12 | KDM4E 4554/4885CA12 1913/4885CA9 3802/4885 |
| US-20100304381-A1 | FLUORESCENT NUCLEOBASE CONJUGATES HAVING ANIONIC LINKERS | DNTT, DUT, NT5C3B | KDM4E 1295/4885CA12 3307/4885CA9 2463/4885 |
| US-20020102590-A1 | Fluorescent nucleobase conjugates having anionic linkers | DNTT, DUT, NT5C3B | KDM4E 1295/4885CA12 3307/4885CA9 2463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.